We’ve all heard the saying, “You are what you eat.” But exactly what about the foods you eat significantly impact your health ...
Liver cancer is one of the deadliest cancers worldwide, often developing silently in an organ crucial for metabolism, energy ...
RAMAT GAN, Israel, Dec. 04, 2024 (GLOBE NEWSWIRE) -- (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a ...
A treatment shown in initial studies to dramatically reduce death could become a "game-changer" in the treatment of liver disease ...
Phil Witkiewicz is a Wisconsin State Patrol lieutenant who has been living with chronic liver disease for more than a decade.
Denifanstat treatment significantly improves liver disease activity among individuals with metabolic dysfunction-associated steatohepatitis.
In 2022, hepatitis B resulted in an estimated 1.1 million deaths globally, mostly from cirrhosis and primary liver cancer.
Switch Therapeutics Inc. has announced its first development candidate, a liver-sparing APOE (apolipoprotein E) RNAi therapy for treatment of Alzheimer’s disease in APOE4 carriers. Switch’s ...
About one-third of US adults without diabetes who are eligible for weight loss treatment with GLP-1 receptor agonists and GLP-1/GIP receptor agonists meet exclusion criteria for clinical trials.
Every year, more and more Americans are being diagnosed with inflammatory bowel disease. Who’s at risk for IBD, and what are ...
Many people assume most individuals addicted to opioids are young. But there’s also a significant population of 65+ addicted ...